Guidelines on nuclear medicine imaging in neuroblastoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29938300.
- Also identified by DOI 10.1007/s00259-018-4070-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nuclear medicine has a central role in the diagnosis, staging, response assessment and long-term follow-up of neuroblastoma, the most common solid extracranial tumour in children. These EANM guidelines include updated information on <sup>123</sup>I-mIBG, the most common study in nuclear medicine for the evaluation of neuroblastoma, and on PET/CT imaging with <sup>18</sup>F-FDG, <sup>18</sup>F-DOPA and <sup>68</sup>Ga-DOTA peptides. These PET/CT studies are increasingly employed in clinical practice. Indications, advantages and limitations are presented along with recommendations on study protocols, interpretation of findings and reporting results.
Medical subject headings
- Diagnostic Imaging
- Neuroblastoma
- Nuclear Medicine
- Practice Guidelines as Topic